Croda International recorded third-quarter sales of £424.7m, reflecting a 4.4% year-on-year increase. The Goole-based chemicals manufacturer said its consumer care division generated £241.6m, while life sciences reached £133.8m and industrial specialties brought in £49.3m.
The company is progressing with a cost transformation programme that aims to deliver £100m in annualised savings by 2027. Around £25m in savings is expected this year as Croda streamlines operations, consolidates manufacturing, and improves procurement processes.
Its full-year forecast remains unchanged, with adjusted pre-tax profits anticipated between £265m and £295m. Croda noted gradual improvement across its key markets, supported by reduced customer destocking and a more stable pricing environment.
The business continues to focus on high-value areas such as life sciences and personal care as it adapts to softer demand in industrial segments. Croda said it remains confident in achieving sustainable earnings growth through disciplined investment and operational efficiency.
